伊曲康唑制剂的临床应用

被引:26
作者
孙黎
刘晓琰
费艳秋
机构
[1] 上海第二医科大学仁济医院临床药学研究室
关键词
伊曲康唑; 临床药理;
D O I
暂无
中图分类号
R978.5 [抗真菌药物];
学科分类号
1007 ;
摘要
引用
收藏
页码:99 / 101
页数:3
相关论文
共 14 条
[1]  
Pharmacology of itraconazole. Karel D B,Jef V G. Drugs . 2001
[2]  
Bone marrow transplantation[P]. REISNER YAIR;MARTELLI MASSIMO.中国专利:US5806529A,1998-09-15
[3]  
Multiple dose pharmacokinetics of an oral solution of itraconazole in autologous bone marrow transplant recipients. Prentice A G,Warnock D W,Johnson S A,et al. Journal of Antimicrobial Chemotherapy . 1994
[4]  
Pharmacokinetics of itraconazole following oral administration to normal volunteers. Hardin T C,Graybill J R,Fetchick R,et al. Antimicrobial Agents and Chemotherapy . 1988
[5]  
Enhanced bioavailability of itraconazole in hydroxypropyl-β-cyclodextrin solution versus capsules in healthy volunteers. Barone J A,Moskovitz B L,Guarnieri J,et al. Antimicrobial Agents and Chemotherapy . 1998
[6]  
Fungal colonization and infection in children with acute leukemia and lymphoma during induction therapy. Gozdasoglu S,Ertem M,Buyukkececi Z,et al. Medical and Pediatric Oncology . 1999
[7]  
Advances in the treatment of superficial fungal infections: focus on onychomycosis and dry tinea pedis. Del Rosso JQ. Journal of the American Osteopathic Association . 1997
[8]  
Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, doubleplacebo, multicenter trial comparing itraconazole and amphotericin B. Harousseau J L,Dekker A W,Stamatoullas-Bastard A,et al. Antimicrobial Agents and Chemotherapy . 2000
[9]  
Itraconazole solution:higher serum drug concentrations and better clinical response rates than the capsuples formulation in acquired immunodeficiency syndrome patients with candidosis. Cartledge J D,Midgely J,Gazzard B G. Journal of Clinical Pathology . 1997
[10]  
Itraconazole in cyclodextrin solution. Stevens D A. Pharmacotherapy . 1999